Diffuse pachymeningeal enhancement is a reliable marker for resolution SIH and often predates clinical resolution. Therefore, the authors propose that assessing for this characteristic with contrasted-brain MRI may assist in the posttreatment evaluation of patients with SIH. https://thejns.org/doi/10.3171/CASE25819.
Esposito et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: